Notícias · Recifes

Halving fertility treatment costs could more than double births, major global study shows

A landmark international study has found that halving patient out-of-pocket costs was associated with a 2.67-fold increase in births achieved through assisted reproductive technology (ART).

Admin Recifes 15/07/2026 2

Pembrolizumab-belzutifan tied to improved disease-free survival in renal cell carcinoma

For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.

Admin Recifes 15/07/2026 2

New study reveals how same day care can ease NHS emergency pressures

A new study led by the University of Sheffield and published in BMJ Open has found that up to one-third of A&E attendances and two-fifths of acute admissions could potentially be managed through same-day emergency care (SDEC) and community settings—keeping patients safe and treat

Admin Recifes 15/07/2026 2

1 in 5 relatives of breast and ovarian cancer patients in Estonia carry dangerous cancer-l

In 2013, Angelina Jolie inspired a wave of testing for pathogenic variants of the gene BRCA1 by announcing that she carried a variant that left her at such high risk of breast cancer that she chose a preventive mastectomy. Many people with similar gene variants won't need risk-re

Admin Recifes 15/07/2026 2

Research shows how behavioral science silently protects American consumers and patients

A new Proceedings of the National Academy of Sciences (PNAS) special feature highlights the critical role of behavioral and decision sciences in U.S. governance. The publications demonstrate how psychological and economic research protect public health, consumer rights and financ

Admin Recifes 15/07/2026 2

AI unlocks previously invisible cortical lesions in MS using legacy MRI scans

One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the disease and how a patient will be affected has been mostly invisible to clinicians.

Admin Recifes 15/07/2026 2

Radioligand therapy significantly prolongs progression-free survival in metastatic GEP-NET

Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) compared with targeted therapy

Admin Recifes 15/07/2026 2

Using AI to provide new insights into why Ebola outcomes differ between patients

There is currently a serious outbreak in the Democratic Republic of the Congo of the severe and often fatal illness. Symptoms include fever, vomiting, diarrhea, severe dehydration and hemorrhage. Rapid clinical deterioration is common. University of Liverpool researchers have led

Admin Recifes 15/07/2026 2

IV vitamin C might boost recuperation among trauma patients

People who've been severely injured in an accident might have a lower risk of death if doctors pump them full of vitamin C, a new evidence review says.

Admin Recifes 15/07/2026 2

First AI agent and risk prediction model for precision diabetes management

A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision Diabetes Management—PIPE-AI" (AI Agent), designed specifically for Asian populations, together with a related disease risk prediction model. Leveraging artifici

Admin Recifes 15/07/2026 2

Promising medication combination to treat an 'undruggable' type of lung cancer

Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for thousands of patients with lung cancer driven by a rare type of KRAS mutation, offering hope for patients worldwide with this difficult-to-treat subtype of

Admin Recifes 15/07/2026 2

Heroin-assisted treatment improves patients' health along with their quality of life

At two clinics in Oslo and Bergen, a small group of patients have been given a new treatment option for opioid addiction. Twice daily, they receive pharmaceutical heroin as medication, administered under close supervision and monitoring by health personnel.

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes